Skip to main content
Retour
Watch Compare

Candel Therapeutics, Inc.

Qualité des données : 83%
CADL
Nasdaq Manufacturing Chemicals
4,83 €
▲ 0,03 € (0,63%)
Cap. Boursière: 353,42 M
Prix
4,83 €
Cap. Boursière
353,42 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -38,90 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-44,83%
Au-dessus de la moyenne du secteur (-53,47%)
ROIC-43,85%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio8,25
Interest Coverage-22,78

Valorisation

PE (TTM)
-9,26
En dessous de la moyenne du secteur (-1,48)
P/B Ratio4,41
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -9,3 -1,5
P/B 4,4 1,6
ROE % -44,8 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Objectif de Cours des Analystes

8 analystes
Buy
Actuel
4,83 €
+290.8%
Objectif
18,88 €
7,00 €
19,50 €
26,00 €
Prévisions
P/E Prévisionnel -7,55
BPA Prévisionnel -0,64 €
CA Est. 54,63 M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2027 -0,64 €
-0,64 € – -0,64 €
 54,63 M 1
FY2026 -0,77 €
-0,77 € – -0,77 €
 0,0 1

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q42025 -0,24 € -0,29 € -23,8%
Q32025 -0,17 € -0,23 € -37,1%
Q22025 -0,18 € -0,20 € -16,6%
Q12025 -0,24 € -0,14 € +42,9%

ETFs Holding This Stock

GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0,01% weight
GCSIX GCSIX
0,01% weight
GCSSX GCSSX
0,01% weight
GCSAX GCSAX
0,01% weight
GCSCX GCSCX
0,01% weight
GDSRX GDSRX
0,01% weight
GDSTX GDSTX
0,01% weight
GMAPX GMAPX
0,01% weight
GCSUX GCSUX
0,01% weight
VVICX VVICX
0,01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -38,18 M
ROE -44,83% ROA -38,27%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -38,90 M
ROIC -43,85% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 8,25
Interest Coverage -22,78 Asset Turnover N/A
Working Capital 79,21 M Tangible Book Value 80,12 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -9,26 Forward P/E N/A
P/B Ratio 4,41 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -11,01%
Market Cap 353,42 M Enterprise Value 266,45 M
Per Share
EPS (Diluted TTM) -0,72 Revenue / Share N/A
FCF / Share -0,53 OCF / Share -0,52
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 101,88%
SBC-Adj. FCF -42,61 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — 125 000,0 125 000,0 125 000,0
Net Income -38,18 M -55,18 M -37,94 M -18,79 M -36,12 M
EPS (Diluted) -0,72 -1,74 -1,31 -0,65 —
Gross Profit — — — — —
Operating Income -48,27 M -33,37 M -38,39 M -34,72 M -25,73 M
EBITDA — — — — —
R&D Expenses 30,50 M 19,31 M 24,51 M 20,79 M 15,18 M
SG&A Expenses — — — — —
D&A — — — 778 000,0 232 000,0
Interest Expense 2,12 M -2,09 M 2,60 M — —
Income Tax 0,0 0,0 0,0 0,0 —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 125,20 M 106,87 M 41,20 M 77,69 M 89,21 M
Total Liabilities 73,27 M 40,54 M 28,46 M 29,98 M 25,07 M
Shareholders' Equity 51,92 M 66,33 M 12,75 M 47,71 M 64,14 M
Total Debt — 1,73 M 11,63 M — 560 000,0
Cash & Equivalents 119,73 M 102,65 M 35,41 M 70,06 M 82,64 M
Current Assets 121,39 M 103,80 M 36,80 M 71,95 M 84,95 M
Current Liabilities 9,00 M 37,53 M 14,18 M 5,62 M 5,36 M